₹ 323.28 Cr
2.46%
BSE Healthcare TRI
INF0QA701995
500.0
100.0
500
Mr. Nimesh Chandan, Mr. Sorbh Gupta, Mr. Siddharth Chaudhary
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW | 9.18 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.27 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.83 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 8.33 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.76 |
| PIRAMAL PHARMA LIMITED EQ | 3.71 |
| Clearing Corporation of India Ltd | 3.68 |
| BIOCON LIMITED EQ | 3.66 |
| Dr. Reddys Laboratories Ltd | 3.45 |
| Net Receivables / (Payables) | 3.15 |
| NEULAND LABORATORIES LIMITED EQ | 2.98 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 81.63 |
| Fast Moving Consumer Goods | 8.4 |
| Consumer Services | 1.15 |
| Financial Services | 1.05 |
| Capital Goods | 0.48 |
| Chemicals | 0.46 |
| Scheme Name | 5Y (%) |
|---|---|
| BAJAJ FINSERV HEALTHCARE FUND REG IDCW | 0.0 |